Compare NINE & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NINE | ALUR |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oilfield Services/Equipment | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.0M | 18.9M |
| IPO Year | 2018 | N/A |
| Metric | NINE | ALUR |
|---|---|---|
| Price | $0.56 | $1.50 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | ★ 3.3M | 109.6K |
| Earning Date | 03-04-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $571,171,000.00 | $17,208,000.00 |
| Revenue This Year | $4.56 | N/A |
| Revenue Next Year | $1.41 | $15.47 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.59 | N/A |
| 52 Week Low | $0.29 | $1.02 |
| 52 Week High | $1.55 | $7.40 |
| Indicator | NINE | ALUR |
|---|---|---|
| Relative Strength Index (RSI) | 61.29 | 47.35 |
| Support Level | $0.43 | $1.28 |
| Resistance Level | $0.67 | $1.57 |
| Average True Range (ATR) | 0.08 | 0.16 |
| MACD | 0.02 | -0.03 |
| Stochastic Oscillator | 62.36 | 34.62 |
Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.